These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 39026999

  • 1. Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis.
    Zhu L, Wei GC, Xiao Q, Chen QL, Zhao Q, Li XX, Pan LA, Xiong X.
    Front Cardiovasc Med; 2024; 11():1383217. PubMed ID: 39026999
    [Abstract] [Full Text] [Related]

  • 2. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 3. A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
    Cushman WC, Bakris GL, White WB, Weber MA, Sica D, Roberts A, Lloyd E, Kupfer S.
    J Hypertens; 2018 Apr; 36(4):947-956. PubMed ID: 29334491
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes.
    White WB, Cuadra RH, Lloyd E, Bakris GL, Kupfer S.
    J Hypertens; 2016 Apr; 34(4):788-97. PubMed ID: 26766564
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension.
    Juhasz A, Wu J, Hisada M, Tsukada T, Jeong MH.
    Clin Hypertens; 2018 Apr; 24():2. PubMed ID: 29445520
    [Abstract] [Full Text] [Related]

  • 16.
    Gartlehner G, Vander Schaaf EB, Orr C, Kennedy SM, Clark R, Viswanathan M.
    ; 2020 11. PubMed ID: 33284560
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril.
    Bönner G, Bakris GL, Sica D, Weber MA, White WB, Perez A, Cao C, Handley A, Kupfer S.
    J Hum Hypertens; 2013 Aug; 27(8):479-86. PubMed ID: 23514842
    [Abstract] [Full Text] [Related]

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 20. The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure.
    Bakris GL, Sica D, Weber M, White WB, Roberts A, Perez A, Cao C, Kupfer S.
    J Clin Hypertens (Greenwich); 2011 Feb 01; 13(2):81-8. PubMed ID: 21272195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.